Navigation Links
The Female Health Company Reports 267% Increase in Second Quarter Earnings
Date:5/14/2008

ing the first half of our 2008 fiscal year," noted O.B. Parrish, Chief Executive Officer of The Female Health Company. "Growing acceptance of the female condom as the only available barrier contraceptive method controlled by women that allows them to protect themselves against HIV/AIDS is the basis for our growth. The FC Female Condom is now available in over 100 countries, and we believe it will play an increasingly important role in the global battle against HIV/AIDS in the future."

"Orders for our second-generation female condom, the FC2, have continued to increase, and we now have four FC2 production lines in Malaysia. Our partner in India, Hindustan Latex Ltd., is operating a production line in that country, which has a population of over one billion people and a rapidly increasing incidence of HIV/AIDS. Lower manufacturing costs for FC2 allow us to sell the second-generation product to public health agencies at a significantly lower price than the FC1, while providing a higher gross profit margin on revenues. This was evident in an expansion in our gross profit margin to 41.5% in the first half of FY2008, from 34.8% in the first half of the previous year."

"In early April, FHC provided earnings guidance for the first time for the full fiscal year 2008. We indicated that we expected unit sales for FY 2008 to increase 20-25% over the 25.9 million units sold in FY 2007 and pre-tax income to increase 100% to 125% over the $868,913 recorded for FY 2007. We confirm the unit sales guidance for FY 2008. We now expect pre-tax income to increase 150-200% over the FY 2007 figure."

"We are optimistic regarding the outlook for The Female Health Company. Our team members are now working with organizations in nearly all regions of the world, from Brazil to Cambodia, from the United Kingdom to India, from New York to South Africa. Given the gravity of the HIV/AIDS pandemic, our results are an indicator of the even greater contribution the female condom wi
'/>"/>

SOURCE The Female Health Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Study: Most female child molesters were victims of sexual abuse
2. Mommy Didnt Know: Female Sexual Offenders in the U.S.
3. Aflac CEO Funds Breast Cancer Symposium in Honor of Companys African-American Female Employees
4. The Female Health Company Schedules Second Quarter Conference Call for May 14, 2008
5. US Female Sterilization Market to Grow to Almost $245 Million Over the Next Five Years
6. Female vets face twice the fertility risk
7. Ingredient found in green tea significantly inhibits breast cancer growth in female mice
8. The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units
9. Correction: Therapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars
10. Photo: Beverly Hills Liposculpture Specializes in Scarless Breast Reduction Dr. Alan Bittner Reduces Female Breasts by up to 50%
11. The Female Health Company to Present at Growth and Value Investor Conference in Ft. Lauderdale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Texas (PRWEB) July 25, 2014 Yisrayl Hawkins, ... Texas, is once again stirring the pot by revealing to ... they are deceived into worshipping Satan, the devil, in his ... clever plan organized by Satan, and carried out by the ... of the Creator from the Inspired Holy Scriptures and replacing ...
(Date:7/25/2014)... 2014 According to the Liver ... by Vkool.com, this is a comprehensive guide that ... and safe remedies for liver cirrhosis . ...     Chapter 1: Liver Cirrhosis Bible ... Learn About Liver Basics ,     Chapter 3: ...
(Date:7/24/2014)... July 25, 2014 iFitDress.com, a renowned ... new range of casual party dresses . According ... party gowns are now offered at discounted prices, up ... this morning until August 04. , Most of ... in the global market. They are popular for special ...
(Date:7/24/2014)... nighttime production of the hormone melatonin, renders breast cancer ... drug, says a new study by Tulane University School ... Disruption by Exposure to Light at Night Drives Intrinsic ... the journal Cancer Research , is the first ... of tamoxifen in treating breast cancer. , , Principal ...
(Date:7/24/2014)... The report, “Content Delivery Networks (CDN) Market”, ... sub-segments with an in-depth analysis and forecasting of ... for this market with insights on trends, opportunities, ... and 36 figures spread through 157 pages and ... at http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . , Early buyers ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Says You Have Been Tricked Into Worshipping Satan in New Article 2Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 2Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 3Health News:2014 Casual Party Dresses for Chic Ladies Now at iFitDress.com 2Health News:Total darkness at night is key to success of breast cancer therapy -- Tulane study 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4
... Buffalo announced today a $10 million gift from Jeremy M. ... Institute, which will support research and clinical collaboration on the ... ... D. Jacobs, M.D., a world-renowned medical pioneer and the late ...
... 13 Elekta, a world-class leader in,advanced ... virtual patient clinic, enabling clinicians, patients and,the ... themselves with,Elekta,s products* and solutions and how ... clinic, available via http://www.elekta.com/evc , ...
... HILL, N.C., June 13 Long and costly ... to,maximize limited staff and resources to the development ... companies are integrating,commercial insights earlier and earlier into ... and target promising compounds, reduce development cycle,time, focus ...
... in diet and other factors , , FRIDAY, June 13 (HealthDay ... advice to people at high risk of heart disease effectively ... cholesterol and smoking. , "The results we see are very ... Dr. David Wood, a cardiology professor at Imperial College in ...
... Friday 13 June 2008: Rheumatoid arthritis (RA), ... should undergo compulsory cardiovascular (CV) risk management and ... the increased CV risk in inflammatory rheumatic disease ... Management in RA, recommended today at EULAR 2008, ...
... WASHINGTON, June 13 A new "hospital report,card" ... the Department,s,health care system high marks, with VA ... accepted by the health,care industry., "This report ... care VA,provides to our veterans," said Dr. James ...
Cached Medicine News:Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 2Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 3Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 4Health News:Elekta Launches Web-based Virtual Clinic, Offers Better Understanding of Radiotherapy Solutions for the Treatment of Cancer 2Health News:Bio-Pharma Launch Value Maximized Through New Product Commercialization Excellence 2Health News:Lifestyle Counseling Reduces Heart Risk 2Health News:Lifestyle Counseling Reduces Heart Risk 3Health News:CV risk management should be mandatory in RA and other types of inflammatory rheumatic disease 2Health News:CV risk management should be mandatory in RA and other types of inflammatory rheumatic disease 3Health News:Health Care 'Report Card' Gives VA High Marks 2
(Date:7/24/2014)... 24, 2014  IRIDEX Corporation (NASDAQ: IRIX ... quarter 2014 financial results after the market closes on ... the release, the Company will host a conference call ... Time on Thursday, July 31, 2014 ... business developments. Interested parties may access the ...
(Date:7/24/2014)... and MENLO PARK, Calif. , July 24, ... ("DelMar" "the company") announced today that the company,s board of ... December 31 to June 30. Accordingly, DelMar will file a ... Jeffrey Bacha , president and CEO of DelMar ... step in achieving our goal of obtaining a senior exchange ...
(Date:7/24/2014)...  Kinex Pharmaceuticals announced the receipt of an allowance ... for the commencement of a Phase I clinical study ... to be allowed by the US FDA in the ... orally active and highly selective inhibitor of Src tyrosine ... of p53, G2/M arrest of proliferating cell populations and ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4
... invivodata inc., the ... and services for global clinical research, today announced ... provide the EXAcerbations of Chronic pulmonary disease Tool ... is a Patient-Reported Outcome (PRO) measure for evaluating ...
... testing in humans watershed moment for unique malaria ... a move that highlights the strength of public-private ... company Sanaria Inc., with support from the PATH ... 1 clinical trial -- the first tests in ...
Cached Medicine Technology:invivodata Certified to Deliver EXACT in COPD Trials 2invivodata Certified to Deliver EXACT in COPD Trials 3Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 2Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 3Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin 4
... are individually adjusted for perfect focus where ... on paper. This, along with Keeler's wide ... that whatever the patient's pupil size, you ... of view. Lithium-ion technology provides a longer ...
... 200 ophthalmoscope, the world's ... ophthalmoscope. Heine's aspherical optical ... along with innovative design ... the Beta 200 the ...
... The Heine Beta 200S is ... with a combination of patented ... and a range of corrective ... dpt. in single diopter steps. ...
... The ophthalmoscope with superior aspherical optics. The ... means of the aspherical optical system avoids ... 200 allows you to view the whole ... even with a small pupil. Conventional ophthalmoscopes ...
Medicine Products: